Literature DB >> 7848924

Arsenate perturbation of human keratinocyte differentiation.

D J Kachinskas1, M A Phillips, Q Qin, J D Stokes, R H Rice.   

Abstract

Treatment of cultured malignant human keratinocytes with sodium arsenate greatly suppressed expression of involucrin, a specific marker of keratinocyte differentiation. This action was primarily attributable to inhibition of involucrin transcription according to message run-on and stability measurements. Involucrin was suppressed in nontumorigenic keratinocytes as well, although the efficacy of suppression was less dramatic in cells derived from clinically normal epidermis. Several transition metal oxyanions (vanadate, molybdate, and tungstate) also substantially suppressed involucrin expression, but okadaic acid was ineffective. Immunoblotting detected marked increases in tyrosine phosphorylation of several proteins as a consequence of arsenate treatment of the cultures, while mobility shift analysis revealed a dramatic loss of DNA binding by the transcription factor AP2. These findings support a proposed role for altered levels of protein tyrosine phosphorylation in keratinocyte differentiation. They also suggest that arsenate perturbs the differentiation program in target cells by altering this phosphorylation level and transcription factor activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848924

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  7 in total

Review 1.  Transcription factor regulation of epidermal keratinocyte gene expression.

Authors:  R L Eckert; J F Welter
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

2.  Arsenite suppression of involucrin transcription through AP1 promoter sites in cultured human keratinocytes.

Authors:  Nadezda N Sinitsyna; Tatiana V Reznikova; Qin Qin; Hyukhwan Song; Marjorie A Phillips; Robert H Rice
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-16       Impact factor: 4.219

3.  Arsenic inhibits myogenic differentiation and muscle regeneration.

Authors:  Yuan-Peng Yen; Keh-Sung Tsai; Ya-Wen Chen; Chun-Fa Huang; Rong-Sen Yang; Shing-Hwa Liu
Journal:  Environ Health Perspect       Date:  2010-03-18       Impact factor: 9.031

4.  Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.

Authors:  D R Germolec; J Spalding; H S Yu; G S Chen; P P Simeonova; M C Humble; A Bruccoleri; G A Boorman; J F Foley; T Yoshida; M I Luster
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  Mouse Huntington's disease homolog mRNA levels: variation and allele effects.

Authors:  Karen T Dixon; Jamie A Cearley; Jesse M Hunter; Peter J Detloff
Journal:  Gene Expr       Date:  2004

6.  Synergistic activation of human involucrin gene expression by Fra-1 and p300--evidence for the presence of a multiprotein complex.

Authors:  James F Crish; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2007-09-20       Impact factor: 8.551

7.  Arsenate-induced apoptosis in murine embryonic maxillary mesenchymal cells via mitochondrial-mediated oxidative injury.

Authors:  Saurabh Singh; Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.